|
|||||
|
|
Defining the optimal approach to the patient with postradiation prostate‐specific antigen recurrence using outcome data from a prospective randomized trial |
|
| Authors: | Miranda B. Kim MD MBA Ming‐Hui Chen PhD Mário de Castro ScD Marian Loffredo RN OCN Philip W. Kantoff MD Anthony V. D'Amico MD PhD |
| Affiliation: | 1. Harvard Radiation Oncology Program, Harvard Medical School, , Boston, Massachusetts;2. Department of Statistics, University of Connecticut, , Storrs, Connecticut;3. Department of Applied Mathematics and Statistics, University of S?o Paulo, , S?o Paulo, Brazil;4. Department of Medical Oncology and Radiation Oncology, Dana‐Farber Cancer Institute and Brigham and Women's Hospital, , Boston, Massachusetts |
| Abstract: | |
| Keywords: | prostate cancer radiation therapy androgen suppression therapy comorbidity prostate‐specific antigen |